Molecular and Genetic Markers in the Local-regional Management of Patients Undergoing Radiation Therapy
OBJECTIVES:
Primary
- Determine local-regional control in patients undergoing radiation therapy for cancer,
as a function of expression of specific molecular/genetic markers.
Secondary
- Determine complications of radiation therapy for patients undergoing radiation therapy
for cancer.
OUTLINE: Previously collected tissue samples are analyzed using immunohistochemical staining
and other molecular/genetic study methods to detect markers, including p53, cyclin D1,
HER-2-neu, bcl-2/BAX, and EGFR. Patient charts are also reviewed with emphasis on
local-regional relapse.
Observational
Observational Model: Case Control, Time Perspective: Retrospective
Bruce G. Haffty, MD
Principal Investigator
Cancer Institute of New Jersey
United States: Institutional Review Board
CDR0000592887
NCT00899808
May 2006
Name | Location |
---|---|
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School | New Brunswick, New Jersey 08903 |